Thural Tablet

About Thural 400 mg Tablet

Thural 400 mg Tablet is an anti-tuberculosis medicine that works against the bacteria causing tuberculosis. It is used together with other anti-tuberculosis medicines, never on its own, as part of a treatment plan set by your doctor.

There are 6 brands of Ethambutol listed in Bangladesh.

What is Thural 400 mg Tablet?

Thural 400 mg Tablet contains ethambutol, an anti-tubercular medicine. It acts on the bacteria that cause tuberculosis and interferes with their ability to grow and multiply, which helps the body clear the infection when it is used alongside other anti-tuberculosis drugs. It is prescribed for pulmonary tuberculosis and is always combined with at least one other anti-tuberculosis medicine chosen by the doctor. The doctor decides the dose, the companion medicines and how long the course lasts. Regular follow-up and eye checks may be part of your treatment.

Uses of Thural

Thural 400 mg Tablet is used in the treatment of pulmonary tuberculosis. It is not used alone; it is given together with other anti-tuberculosis medicines as part of a combination regimen. The choice of the other medicines and the length of treatment are decided by the doctor based on your condition. Never start, stop or change this medicine without medical advice.

How to use Thural

Take Thural 400 mg Tablet exactly as your doctor prescribes. The doctor decides the dose, how often to take it and how long the course should continue. Swallow the tablet with water; food does not significantly affect how it is absorbed. Do not skip doses or stop early, even if you feel better, because stopping too soon can allow the infection to return. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Thural

Tell your doctor about any change in your vision, such as blurred sight, reduced colour vision, or trouble seeing parts of your visual field, as these need urgent medical attention. Other side effects can include nausea, vomiting, loss of appetite, abdominal pain, headache, dizziness, confusion, joint pain, rash, itching or fever. Some people may develop gout or liver problems. Call your doctor promptly if any side effect worries you or does not settle.

Safety and precautions

Before taking Thural 400 mg Tablet, tell your doctor if you have eye problems such as cataracts or recurring eye inflammation, diabetes with nerve damage, kidney problems, or if you are pregnant or breastfeeding. This medicine is not suitable for people who are allergic to it, who have optic neuritis (unless the doctor decides otherwise), or who cannot notice or report changes in their vision. The doctor will decide whether it is appropriate for you and will arrange any monitoring needed.

Frequently asked questions

What is Thural 400 mg Tablet used for and what kind of medicine is it?

Thural 400 mg Tablet is an anti-tubercular medicine containing ethambutol. It is used for pulmonary tuberculosis and is always given together with at least one other anti-tuberculosis medicine. It is not used alone, and the doctor decides the full combination and course.

What side effects should I watch for, and when should I call the doctor?

Watch for any change in vision, such as blurring, reduced colour vision or trouble seeing parts of your visual field, and contact your doctor promptly. Also report nausea, vomiting, loss of appetite, abdominal pain, headache, dizziness, confusion, joint pain, rash, itching, fever or yellowing of the skin to your doctor.

How should I store Thural 400 mg Tablet?

Store Thural 400 mg Tablet in a cool, dry place away from light, moisture and excessive heat. Keep it out of reach of children. Do not use it after the expiry date printed on the pack, and ask your pharmacist if you are unsure how to dispose of unused tablets.

Can I stop taking Thural 400 mg Tablet when I feel better?

No. Do not stop or change this medicine without your doctor's advice, even if you feel better. The course length is set by your doctor, and stopping early can allow the infection to come back. Ask your doctor or pharmacist if you have questions about your treatment.

Indications

Ethambutol is indicated for the treatment of pulmonary tuberculosis. It should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. Selection of the companion drug should be based on clinical experience, considerations of ... Read moreEthambutol is indicated for the treatment of pulmonary tuberculosis. It should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. Selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. In patients who have not received previous antituberculous therapy, ie, initial treatment, the most frequently used regimens have been the following:
  • Ethambutol plus isoniazid
  • Ethambutol plus isoniazid plus streptomycin.
In patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. Consequently, in such retreatment patients, Ethambutol should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. Antituberculous drugs used with Ethambutol have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. Isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. Alternating drug regimens have also been utilized.

Pharmacology

Ethambutol appears to inhibit the synthesis of 1 or more metabolites in susceptible bacteria resulting in impairment of cellular metabolism, arrest of multiplication, and cell death. It is active against susceptible bacteria only when they are undergoing cell division.

Dosage & Administration

Ethambutol should not be used alone, in initial treatment or in retreatment. Ethambutol should be administered on a once every 24-hour basis only. Absorption is not significantly altered by administration with food. Therapy, in general, should be continued until bacteriological conversion has become permanent and maximal clinical improvement has occurred.

Ethambutol is not recommended for use in pediatric patients under thirteen years of age since safe conditions for use have not been established.

Initial Treatment: In patients who have not received previous antituberculous therapy, administer Ethambutol 15 mg/kg of body weight, as a single oral dose once every 24 hours. In the more recent studies, isoniazid has been administered concurrently in a single, daily, oral dose.

Retreatment: In patients who have received previous antituberculous therapy, administer Ethambutol 25 mg/kg of body weight, as a single oral dose once every 24 hours. Concurrently administer at least one other antituberculous drug to which the organisms have been demonstrated to be susceptible by appropriate in vitro tests. Suitable drugs usually consist of those not previously used in the treatment of the patient. After 60 days of Ethambutol administration, decrease the dose to 15 mg/kg of body weight, and administer as a single oral dose once every 24 hours.

During the period when a patient is on a daily dose of 25 mg/kg, monthly eye examinations are advised.

Renal Impairment: Dose adjustment may be needed as determined by blood levels of ethambutol.

Interaction

Delayed or reduced absorption with aluminium hydroxide.

Contraindications

Ethambutol is contraindicated in patients who are known to be hypersensitive to this drug. It is also contraindicated in patients with known optic neuritis unless clinical judgment determines that it may be used. Ethambutol is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision

Side Effects

Retrobulbar neuritis with reduction in visual acuity, constriction of visual field, central or peripheral scotoma and green-red colour blindness of 1 or both eyes. Reduced renal clearance of urate and may precipitate acute gout. Confusion, disorientation, hallucinations, headache, dizziness, malaise, jaundice or transient liver dysfunction, peripheral neuropathy, thrombocytopenia, pulmonary infiltrates, eosinophilia and GI disturbances (e.g. nausea, vomiting, anorexia, abdominal pain). Rarely, retinal haemorrhage, hypersensitivity reactions including rashes, pruritus, leucopenia, fever, and joint pains.

Pregnancy & Lactation

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.

Precautions & Warnings

Patient with ocular defects (e.g. cataracts, recurrent ocular inflammatory conditions, diabetic neuropathy). Renal impairment. Pregnancy and lactation.

Storage Conditions

Store between 20-25°C. Protect from light, moisture and excessive heat.

Alternative brands of Ethambutol

Other brands with the same generic name, cheapest first.

Etham Tablet

400 mg

Ethambutol

Chemist Laboratories Ltd.

Price not listed

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.